NASDAQ : WGS
GeneDx Holdings Corp. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 71.02 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
GeneDx Holdings Corp. (WGS) reported revenue of 454.43M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 443.99M | 416.67M | 302.16M | 195.65M | 227.33M | 205.10M |
| Other Revenue | 10.43M | 10.87M | 3.29M | 6.91M | 7.36M | 7.09M |
| Revenue | 454.43M | 427.54M | 305.45M | 202.57M | 234.69M | 212.19M |
| Cost of Revenue | 139.13M | 129.36M | 111.00M | 112.42M | 261.44M | 228.80M |
| Gross Profit | 315.30M | 298.18M | 194.45M | 90.14M | -26.75M | -16.60M |
| Selling, General & Admin | 291.14M | 237.82M | 171.89M | 199.98M | 338.24M | 324.38M |
| Research & Development | 83.83M | 72.03M | 45.72M | 58.27M | 86.20M | 105.16M |
| Other Operating Expenses | 1.96M | 6.31M | ||||
| Operating Expenses | 374.97M | 309.85M | 217.61M | 260.20M | 430.76M | 429.55M |
| Operating Income | -59.67M | -11.67M | -23.16M | -170.06M | -457.51M | -446.15M |
| Interest Expense | -2.98M | -2.54M | -3.03M | -666.00K | -2.83M | |
| Interest & Investment Income | 1.11M | 79.00K | ||||
| Other Non Operating Income (Expenses) | 683.00K | -1.20M | -13.58M | 1.17M | 70.29M | 198.22M |
| EBT Excluding Unusual Items | -61.97M | -15.41M | -39.77M | -167.77M | -387.89M | -250.69M |
| Merger & Restructuring Charges | -1.45M | -1.41M | -54.00K | -139.00K | ||
| Asset Writedown | -31.29M | -10.40M | -210.15M | |||
| Legal Settlements | -4.80M | -4.80M | -12.80M | |||
| Other Unusual Items | -6.78M | 483.00K | 1.62M | 5.30M | ||
| Pretax Income | -106.30M | -21.14M | -52.63M | -176.69M | -598.03M | -245.39M |
| Income Tax Expense | 62.00K | -116.00K | -343.00K | -926.00K | -49.05M | |
| Net Income | -106.36M | -21.02M | -52.29M | -175.77M | -548.98M | -245.39M |
| Net Income to Common | -106.36M | -21.02M | -52.29M | -175.77M | -548.98M | -245.39M |
| Shares Outstanding (Basic) | 29.22M | 28.64M | 26.89M | 24.31M | 10.24M | 3.28M |
| Shares Outstanding (Diluted) | 29.22M | 28.64M | 26.89M | 24.31M | 10.24M | 3.28M |
| EPS (Basic) | -3.64 | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
| EPS (Diluted) | -3.64 | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
| Free Cash Flow | -75.80M | 14.26M | -33.99M | -185.40M | -326.31M | -199.83M |
| Free Cash Flow Per Share | -2.59 | 0.50 | -1.26 | -7.63 | -31.88 | -61.02 |
| Gross Margin | 69.38% | 69.74% | 63.66% | 44.50% | -11.40% | -7.82% |
| Operating Margin | -13.13% | -2.73% | -7.58% | -83.95% | -194.94% | -210.25% |
| Profit Margin | -23.41% | -4.92% | -17.12% | -86.77% | -233.91% | -115.64% |
| Free Cash Flow Margin | -16.68% | 3.34% | -11.13% | -91.52% | -139.04% | -94.17% |
| EBITDA | -33.70M | 12.65M | -2.11M | -142.92M | -413.60M | -429.94M |
| EBITDA Margin | -7.41% | 2.96% | -0.69% | -70.56% | -176.23% | -202.62% |
| D&A For EBITDA | 25.98M | 24.32M | 21.05M | 27.13M | 43.91M | 16.21M |
| EBIT | -59.67M | -11.67M | -23.16M | -170.06M | -457.51M | -446.15M |
| EBIT Margin | -13.13% | -2.73% | -7.58% | -83.95% | -194.94% | -210.25% |
| Revenue as Reported | 454.43M | 427.54M | 305.45M | 202.57M | 234.69M | 212.19M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 60.32M | 105.00M | 85.21M | 99.68M | 123.93M | 400.57M |
| Short-Term Investments | 72.23M | 66.28M | 55.97M | 30.47M | ||
| Cash & Short-Term Investments | 132.55M | 171.28M | 141.19M | 130.15M | 123.93M | 400.57M |
| Accounts Receivable | 83.61M | 74.37M | 37.63M | 32.82M | 43.34M | 26.56M |
| Other Receivables | 1.30M | |||||
| Receivables | 83.61M | 74.37M | 37.63M | 32.82M | 44.64M | 26.56M |
| Inventory | 17.82M | 13.95M | 10.65M | 8.78M | 13.66M | 33.46M |
| Prepaid Expenses | 11.35M | 7.17M | 7.42M | 8.64M | 16.61M | 19.15M |
| Restricted Cash | 13.47M | |||||
| Other Current Assets | 1.03M | 1.51M | 1.08M | 1.96M | 300.00K | 3.80M |
| Total Current Assets | 246.36M | 268.29M | 197.97M | 182.34M | 212.62M | 483.54M |
| Property, Plant & Equipment | 87.85M | 69.11M | 58.51M | 59.38M | 84.28M | 62.72M |
| Goodwill | 1.64M | 13.52M | ||||
| Other Intangible Assets | 141.35M | 168.48M | 158.60M | 172.62M | 186.65M | |
| Other Long-Term Assets | 4.28M | 4.32M | 4.31M | 4.41M | 7.38M | 7.83M |
| Total Assets | 481.49M | 523.71M | 419.38M | 418.76M | 490.94M | 554.09M |
| Accounts Payable | 5.15M | 2.46M | 7.95M | 10.24M | 46.02M | 44.69M |
| Accrued Expenses | 47.48M | 75.71M | 30.10M | 27.88M | 44.20M | 47.19M |
| Current Portion of Long-Term Debt | 4.54M | 1.21M | 4.75M | |||
| Current Portion of Leases | 5.71M | 4.40M | 3.34M | 3.65M | 6.12M | |
| Current Unearned Revenue | 473.00K | |||||
| Other Current Liabilities | 16.29M | 21.79M | 12.22M | 17.06M | 43.21M | 8.93M |
| Total Current Liabilities | 74.63M | 108.91M | 54.82M | 58.82M | 144.30M | 101.28M |
| Long-Term Debt | 96.84M | 48.18M | 51.91M | 52.69M | 6.25M | 11.00M |
| Long-Term Leases | 64.86M | 56.05M | 60.92M | 62.94M | 60.01M | |
| Long-Term Deferred Tax Liabilities | 873.00K | 757.00K | 965.00K | 1.56M | 2.66M | |
| Other Long-Term Liabilities | 71.00K | 1.64M | 5.52M | 14.73M | 24.02M | 53.71M |
| Total Liabilities | 237.26M | 215.53M | 174.13M | 190.74M | 237.24M | 165.99M |
| Common Stock | 3.00K | 3.00K | 2.00K | 2.00K | 1.00K | 24.00K |
| Additional Paid-In Capital | 1.70B | 1.68B | 1.60B | 1.53B | 1.38B | 963.52M |
| Retained Earnings | -1.45B | -1.37B | -1.35B | -1.30B | -1.12B | -575.44M |
| Comprehensive Income & Other | 342.00K | 936.00K | 830.00K | 425.00K | ||
| Total Common Equity | 244.22M | 308.18M | 245.25M | 228.02M | 253.71M | 388.10M |
| Shareholders' Equity | 244.22M | 308.18M | 245.25M | 228.02M | 253.71M | 388.10M |
| Total Liabilities & Equity | 481.49M | 523.71M | 419.38M | 418.76M | 490.94M | 554.09M |
| Total Debt | 167.40M | 113.17M | 117.38M | 119.27M | 77.13M | 11.00M |
| Net Cash (Debt) | -34.85M | 58.11M | 23.81M | 10.88M | 46.80M | 389.57M |
| Net Cash Per Share | -1.19 | 2.03 | 0.89 | 0.45 | 4.57 | 118.95 |
| Filing Date Shares Outstanding | 29.82M | 29.29M | 28.07M | 26.05M | 24.19M | 7.42M |
| Total Common Shares Outstanding | 29.80M | 29.25M | 28.02M | 25.98M | 11.77M | 7.35M |
| Working Capital | 171.73M | 159.38M | 143.15M | 123.52M | 68.33M | 382.26M |
| Book Value Per Share | 8.19 | 10.54 | 8.75 | 8.78 | 21.55 | 52.78 |
| Tangible Book Value | 101.23M | 126.18M | 86.65M | 55.39M | 67.06M | 388.10M |
| Tangible Book Value Per Share | 3.40 | 4.31 | 3.09 | 2.13 | 5.70 | 52.78 |
| Machinery | 54.06M | 43.74M | 25.76M | 21.91M | 54.21M | 38.43M |
| Construction In Progress | 11.67M | 7.45M | 4.96M | 3.11M | 3.39M | 940.00K |
| Leasehold Improvements | 14.81M | 14.80M | 14.65M | 14.61M | 35.56M | 21.91M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -106.36M | -21.02M | -52.29M | -175.77M | -548.98M | -245.39M |
| Depreciation & Amortization | 25.98M | 24.32M | 21.05M | 27.13M | 43.91M | 16.21M |
| Other Amortization | 2.60M | 15.40M | 5.67M | |||
| Asset Writedown & Restructuring Costs | 32.19M | 900.00K | 900.00K | 14.40M | 210.15M | |
| Stock-Based Compensation | 35.70M | 32.16M | 9.14M | -326.00K | 41.98M | 219.42M |
| Other Operating Activities | 12.19M | 12.51M | 17.44M | -9.95M | -115.48M | -194.42M |
| Change in Accounts Receivable | -35.58M | -36.23M | -5.18M | 10.53M | 5.53M | 5.54M |
| Change in Inventory | -6.00M | -3.44M | -2.58M | 975.00K | 2.35M | -10.62M |
| Change in Accounts Payable | -7.67M | 12.10M | -20.52M | -49.17M | 34.46M | 25.92M |
| Change in Unearned Revenue | -1.31M | |||||
| Change in Other Net Operating Assets | 843.00K | 11.97M | 3.54M | -575.00K | -8.46M | -11.44M |
| Operating Cash Flow | -48.71M | 33.28M | -28.50M | -180.15M | -319.15M | -190.43M |
| Capital Expenditures | -27.09M | -19.02M | -5.49M | -5.25M | -7.16M | -9.40M |
| Sale of Property, Plant & Equipment | 4.03M | |||||
| Cash Acquisitions | 339.00K | -32.86M | -12.14M | -127.00M | ||
| Sale (Purchase) of Intangibles | -461.00K | -7.17M | -11.39M | |||
| Investment in Securities | -11.90M | -9.64M | -24.64M | -29.91M | ||
| Investing Cash Flow | -38.64M | -61.52M | -30.13M | -43.73M | -141.33M | -20.79M |
| Long-Term Debt Issued | 48.55M | |||||
| Long-Term Debt Repaid | -3.66M | -3.23M | -5.60M | -3.29M | -13.47M | |
| Net Debt Issued (Repaid) | 35.37M | -3.66M | -3.23M | 42.95M | -3.29M | -13.47M |
| Issuance of Common Stock | 38.19M | 51.69M | 47.39M | 143.29M | 200.61M | 351.27M |
| Other Financing Activities | 155.93M | |||||
| Financing Cash Flow | 73.56M | 48.02M | 44.16M | 186.24M | 197.31M | 493.73M |
| Net Cash Flow | -13.80M | 19.79M | -14.47M | -37.63M | -263.17M | 282.51M |
| Free Cash Flow | -75.80M | 14.26M | -33.99M | -185.40M | -326.31M | -199.83M |
| Free Cash Flow Margin | -16.68% | 3.34% | -11.13% | -91.52% | -139.04% | -94.17% |
| Free Cash Flow Per Share | -2.59 | 0.50 | -1.26 | -7.63 | -31.88 | -61.02 |
| Levered Free Cash Flow | -47.50M | 38.06M | -1.16M | -124.34M | -172.97M | -43.99M |
| Unlevered Free Cash Flow | -45.64M | 39.64M | 732.62K | -124.34M | -172.55M | -42.28M |
| Cash Interest Paid | 7.02M | 6.41M | 6.68M | 3.04M | 1.93M | 2.75M |
| Cash Income Tax Paid | 2.58M | 1.27M | 1.17M | 1.47M | 1.24M | 349.00K |
| Change in Working Capital | -48.41M | -15.60M | -24.75M | -38.24M | 33.88M | 8.08M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.92B | 3.76B | 2.11B | 71.18M | 102.04M | 1.08B |
| Enterprise Value | 1.95B | 3.72B | 2.11B | 30.70M | -10.92M | 648.20M |
| Last Close Price | 69.06 | 130.06 | 76.86 | 2.75 | 8.71 | 147.18 |
| Forward PE | 104.18 | 250.14 | 190.96 | |||
| PS Ratio | 4.27 | 8.79 | 6.91 | 0.35 | 0.43 | 5.07 |
| PB Ratio | 8.43 | 12.20 | 8.61 | 0.31 | 0.40 | 2.77 |
| P/TBV Ratio | 19.16 | 29.79 | 24.37 | 1.28 | 1.52 | 2.77 |
| P/FCF Ratio | 263.59 | |||||
| P/OCF Ratio | 112.96 | |||||
| PEG Ratio | 1.62 | |||||
| EV/Sales Ratio | 4.34 | 8.70 | 6.91 | 0.15 | 3.06 | |
| EV/EBITDA Ratio | 293.82 | |||||
| EV/FCF Ratio | 260.65 | |||||
| Debt / Equity Ratio | 0.69 | 0.37 | 0.48 | 0.52 | 0.30 | 0.03 |
| Debt / EBITDA Ratio | 5.46 | 23.55 | ||||
| Debt / FCF Ratio | 7.93 | |||||
| Net Debt / Equity Ratio | 0.14 | -0.19 | -0.10 | -0.05 | -0.18 | -1.00 |
| Net Debt / EBITDA Ratio | -1.03 | -4.59 | 11.30 | 0.08 | 0.11 | 0.91 |
| Net Debt / FCF Ratio | -0.46 | -4.08 | 0.70 | 0.06 | 0.14 | 1.95 |
| Asset Turnover | 0.96 | 0.91 | 0.73 | 0.45 | 0.45 | 0.53 |
| Inventory Turnover | 9.35 | 10.52 | 11.43 | 10.02 | 11.10 | 7.83 |
| Quick Ratio | 2.90 | 2.26 | 3.26 | 2.77 | 1.17 | 4.22 |
| Current Ratio | 3.30 | 2.46 | 3.61 | 3.10 | 1.47 | 4.77 |
| Return on Equity (ROE) | -40.80% | -7.60% | -22.10% | -72.97% | -171.07% | -125.04% |
| Return on Assets (ROA) | -7.89% | -1.55% | -3.45% | -23.37% | -54.72% | -69.21% |
| Return on Capital Employed (ROCE) | -14.70% | -2.80% | -6.40% | -47.20% | -132.00% | -98.50% |
| Earnings Yield | -5.66% | -0.56% | -2.48% | -246.93% | -538.02% | -22.80% |
| FCF Yield | -3.91% | 0.38% | -1.61% | -260.46% | -319.80% | -18.57% |
| Buyback Yield / Dilution | -2.38% | -6.51% | -10.61% | -137.49% | -212.57% |